In patients with type 2 diabetes, chronic kidney disease and albuminuria, is finerenone, a selective minerocorticoid receptor antagonist, effective and safe for lowering CKD progression?

被引：0
|
作者：
Lanthier, L. [1 ]
Plourde, M-E [2 ]
Cauchon, M. [3 ]
机构：
[1] Univ Sherbrooke, Dept Med Specialise, Serv Med Interne Gen, Sherbrooke, PQ, Canada
[2] Univ Sherbrooke, Dept Med Nucl & Radiobiol, Serv Radiooncol, Sherbrooke, PQ, Canada
[3] Univ Laval, Dept Med Familiale & Med Urgence, Quebec City, PQ, Canada
来源：
REVUE DE MEDECINE INTERNE | 2021年 / 42卷 / 02期
关键词：
NEPHROPATHY;
D O I：
10.1016/j.revmed.2020.12.013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：144 / 145
页数：2
相关论文
共 50 条
  • [41] Finerenone and left ventricular hypertrophy in chronic kidney disease and type 2 diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Bakris, George L.
    Rossing, Peter
    Ruilope, Luis M.
    Coats, Andrew J. S.
    von Haehling, Stephan
    Ponikowski, Piotr
    Rosano, Giuseppe M. C.
    Brinker, Meike
    Farjat, Alfredo E.
    Roberts, Luke
    Pitt, Bertram
    ESC HEART FAILURE, 2025, 12 (01): : 185 - 188
  • [42] FINERENONE ADDED TO TREATMENT GUIDELINES FOR TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2023, 123 (05) : 23 - 23
  • [43] IMPACT OF INCLUSION OF FINERENONE IN THE BURDEN OF DISEASE OF CHRONIC KIDNEY DISEASE (CKD) IN TYPE 2 DIABETES (T2D) IN CENTRAL AMERICA
    Lopez-Cabra, C.
    Rodriguez, A. D.
    Mogollon, W. Mayorga
    Chavez, M. A.
    Patino, A.
    Herran, S. E.
    Marrugo, R.
    VALUE IN HEALTH, 2023, 26 (06) : S159 - S159
  • [44] Incidence of Chronic Kidney Disease and Progression of Renal Dysfunction in Type 2 Diabetes-The Role of Albuminuria
    Nichols, Gregory
    Deruaz-Luyet, Anouk
    Hauske, Sibylle
    Brodovicz, Kimberly
    DIABETES, 2018, 67
  • [45] Impact of finerenone on chronic kidney disease progression in Chinese patients with type 2 diabetes: subgroup analysis of the FIGARO-DKD trial
    Li, P.
    Zheng, H.
    Ma, J.
    Lu, W.
    Li, L.
    Liu, F.
    Su, Q.
    Li, Y.
    Fang, Y.
    Mo, Z.
    Xiong, F.
    Yin, A.
    Zhang, Y.
    Wang, L.
    Zhu, D.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S356 - S356
  • [46] DAPAGLIFLOZIN DECREASES ALBUMINURIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE WITH AND WITHOUT TYPE 2 DIABETES: INSIGHTS FROM THE DAPA-CKD TRIAL
    Jong, Niels
    Chertow, Glenn
    Hou, Fan Fan
    McMurray, John
    Correa-Rotter, Ricardo
    Rossing, Peter
    Sjostrom, David
    Stefansson, Bergur
    Toto, Robert
    Langkilde, Anna Maria
    Wheeler, David C.
    Heerspink, Hiddo Lambers
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [47] Efficacy and safety of finerenone by age and sex subgroups in patients with chronic kidney disease and type 2 diabetes
    Bansal, S.
    Anker, S.
    Bakris, G.
    Filippatos, G.
    Rossing, P.
    Ruilope, L.
    Birne, R.
    Canziani, M.
    Farjat, A.
    Brinker, M.
    Pitt, B.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [48] Hypokalaemia in patients with type 2 diabetes and chronic kidney disease: the effect of finerenone-a FIDELITY analysis
    Pitt, Bertram
    Agarwal, Rajiv
    Anker, Stefan D.
    Rossing, Peter
    Ruilope, Luis
    Herzog, Charles A.
    Greenberg, Barry
    Pecoits-Filho, Roberto
    Lambelet, Marc
    Lawatscheck, Robert
    Scalise, Andrea
    Filippatos, Gerasimos
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2024, 11 (01) : 10 - 19
  • [49] Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone
    Agarwal, Rajiv
    Anker, Stefan D.
    Bakris, George
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Ruilope, Luis
    Gebel, Martin
    Kolkhof, Peter
    Nowack, Christina
    Joseph, Amer
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (06) : 1014 - 1023
  • [50] Effect of finerenone on the incidence of hypokalemia in patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis
    Pitt, B.
    Agarwal, R.
    Anker, S.
    Bakris, G.
    Rossing, P.
    Ruilope, L.
    Herzog, C.
    Greenberg, B.
    Pecoits-Filho, R.
    Zannad, F.
    Lambelet, M.
    Lawatscheck, R.
    Scalise, A.
    Filippatos, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 415 - 415
12345